Gentiva Health Services (NASDAQ: GTIV) is in a space that's often overlooked by health care analysts; the company provides a variety of important health care services, such as nursing, to patients in both hospices and in their own homes.
Gentiva reported its third-quarter earnings today and posted a 6% drop in year-over-year revenue. Despite these seemingly poor results, its share price spiked an impressive 22%. What caused this surge? Can investors compare these report to upcoming earnings releases from competitors Amedisys (AMED 0.69%) and the LHC Group (LHCG)?
In the following video, health care analysts Max Macaluso and David Williamson discuss this quarter's earnings and why Gentiva's share price soared.
